title: Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.
authors.forename: Megan
authors.initials: M
authors.lastname: Miller
authors.forename: Avinash B
authors.initials: AB
authors.lastname: Kumar
authors.forename: Charles R
authors.initials: CR
authors.lastname: Callison
mesh_terms: D000328:Adult; D002110:Caffeine / Q000009:adverse effects*; D002533:Cerebral Angiography; D004087:Dihydroergotamine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D018810:Magnetic Resonance Angiography; D008881:Migraine Disorders / Q000188:drug therapy*; D009529:Nicardipine / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D015607:Stents; D020521:Stroke / Q000139:chemically induced* / Q000628:therapy*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*; D014665:Vasodilator Agents / Q000627:therapeutic use; D020301:Vasospasm, Intracranial / Q000139:chemically induced* / Q000628:therapy*
chemical_list: D010726:Phosphodiesterase Inhibitors; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D002110:Caffeine; D004087:Dihydroergotamine; D009529:Nicardipine